About Reenav Pharma Private Limited
Data last updated:
Reenav Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Ascent Wellness And Pharma Solutions Private Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC308208. Its GSTIN is 27AAICR8983Q1Z4 (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Arvind Govind Varia and Rajeshree Trikamlal Gor.
Its last annual general meeting (AGM) was held on 29 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 607 6th Floor Skyline Epitome Building Near Jolly Gymkhana Vidyavihar West, Mumbai, Maharashtra, India – 400086.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.22 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹12.7 Lakh (net margin 5.7%) and EBITDA of ₹27.4 Lakh (EBITDA margin 12.4%). Revenue has declined at a compounded annual rate (CAGR) of 78% over three years and 50% over five years.
Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending. The company has 5 deals on record (4 secondary share transfers, 1 debt financing), with disclosed funding of ₹1.2 Cr; the latest was in August 2020. Its 10 peer companies in the same principal business activity (Wholesale Trading) are compared by revenue, 5 larger and 5 smaller; the largest is Negbuy Private Limited. The company has 4 MSME Form 1 returns on record between 2019 and 2020, listing 52 overdue payments to 1 micro and small supplier.
For more details, the company can be reached via its website reenavpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address607 6th Floor Skyline Epitome Building Near Jolly Gymkhana Vidyavihar West, Mumbai, Maharashtra, India – 400086
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Reenav Pharma Private Limited
The main business activity of Reenav Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Reenav Pharma Private Limited FY 2024 filings available
Reenav Pharma Private Limited reported revenue of ₹2.22 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Reenav Pharma Private Limited
Revenue rose 9% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 50%. EBITDA rose 226% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Reenav Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹27.4 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹12.7 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Reenav Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Reenav Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Reenav Pharma Private Limited
Reenav Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Negbuy Private Limited | •••• | •••• | •••• | •••• | - | South Delhi, Delhi, India |
| Shivshakti Agencies Private Limited | •••• | •••• | •••• | •••• | - | Uluberia - I, West Bengal, India |
| MTC Disposable Eco Products Private Limited | •••• | •••• | •••• | •••• | - | Surat, Gujarat, India |
| Hemalite Products Private Limited | •••• | •••• | •••• | •••• | - | Chennai, Tamil Nadu, India |
| Sisumara Trading Private Limited | •••• | •••• | •••• | •••• | - | Kolkata, West Bengal, India |
| Reenav Pharma Private Limited this company | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Opus Innovation Private Limited | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Rd Strategic Esales Private Limited | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Avigenix Innovations Private Limited | •••• | •••• | •••• | •••• | 15 | Kolkata, West Bengal, India |
| Kokane Farmer Producer Company Limited | •••• | •••• | •••• | •••• | - | Nanded, Maharashtra, India |
| Richa Paints and Stones Private Limited | •••• | •••• | •••• | •••• | - | Kota, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Reenav Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Reenav Pharma Private Limited
Reenav Pharma Private Limited is audited by Price Waterhouse Chartered Accountants LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Price Waterhouse Chartered Accountants LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Reenav Pharma Private Limited
Reenav Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvind Govind Varia Also directs: Reenav Logistics Private Limited | Director | 18 Apr 2018 | 8 Years 5 Months | Current |
| Rajeshree Trikamlal Gor Also directs: Reenav Logistics Private Limited | Director | 18 Apr 2018 | 8 Years 5 Months | Current |
Ownership and Shareholding of Reenav Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Reenav Pharma Private Limited
Reenav Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Reenav Pharma Private Limited
Reenav Pharma Private Limited has 5 deals on record (4 secondary share transfers, 1 debt financing), with disclosed funding of ₹1.2 Cr; the latest was in August 2020.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2020 | Secondary share transfer | Undisclosed | Buyer: Ascent Wellness and Pharma Solutions Private Limited Seller: Api Holdings Limited |
| Aug 2020 | Secondary share transfer | Undisclosed | Buyer: Api Holdings Limited Seller: Ascent Health and Wellness Solutions Private Limited |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: Ascent Health and Wellness Solutions Private Limited Seller: 2 individuals |
| Nov 2018 | Debt financing | ₹1.2 Cr | Investors: Ascent Health and Wellness Solutions Private Limited |
| Oct 2018 | Secondary share transfer | Undisclosed | Buyer: Ascent Health and Wellness Solutions Private Limited Seller: 2 individuals |
Full deal history
All 5 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Reenav Pharma Private Limited
Reenav Pharma Private Limited has 1 court case on record: 1 filed by Reenav Pharma. All case is pending. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case SC) | Filed by the company against an individual | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Reenav Pharma Private Limited
Reenav Pharma Private Limited has 4 MSME Form 1 returns on record between 2019 and 2020, listing 52 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Miraclus Orthotech Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 4 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Reenav Pharma Private Limited
Employment history and EPFO contributions of people linked to Reenav Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Reenav Pharma Private Limited
Reenav Pharma Private Limited has 5 board changes on record since 2018: 2 appointments and 3 cessations. The latest: Anand Subramanian Iyer ceased to be Additional Director on 24 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts for Reenav Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Reenav Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Reenav Pharma Private Limited
Reenav Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICR8983Q1Z4 | Maharashtra | Active | 28 Jun 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Reenav Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reenav Pharma Private Limited
Reenav Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 April 2018 (8+ years old) and is registered under CIN U74999MH2018PTC308208.
Reenav Pharma reported revenue of ₹2.22 Cr for FY 2025 (up 9% YoY).
Reenav Pharma has 2 current directors:
- Arvind Govind Varia - Director
- Rajeshree Trikamlal Gor - Director
Reenav Pharma reported a net profit of ₹12.7 Lakh (net margin 5.7%) and EBITDA of ₹27.4 Lakh (EBITDA margin 12.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Reenav Pharma is -78% over three years and -50% over five years. In the latest year (FY 2025) revenue rose 9%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Reenav Pharma is 27AAICR8983Q1Z4, registered in Maharashtra.
The CIN (Corporate Identification Number) of Reenav Pharma is U74999MH2018PTC308208. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reenav Pharma has 1 court case on record: 1 filed by the company. 1 is pending.
Reenav Pharma was incorporated on 18 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Reenav Pharma has 5 deals on record (4 secondary share transfers, 1 debt financing), with disclosed funding of ₹1.2 Cr; the latest was in August 2020.
The peers of Reenav Pharma by revenue are Negbuy Private Limited, Shivshakti Agencies Private Limited, MTC Disposable Eco Products Private Limited, Hemalite Products Private Limited, Sisumara Trading Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Anand Subramanian Iyer ceased to be Additional Director on 24 Sep 2022. Kalpana Srinivasan ceased to be Additional Director on 24 Sep 2022. Jay Rajesh Mehta ceased to be Director on 13 May 2022. Reenav Pharma has 5 board changes on record in total.